Paratiroid Hastalıkları ve Nörolojik Tutulum
Özet
Paratiroid hormonu (PTH), vücuttaki kalsiyum ve fosfat dengesini düzenleyen, kemik, böbrek ve bağırsaklar üzerinde kritik rollere sahip 84 aminoasitli bir polipeptiddir. Paratiroid hastalıkları hiperparatiroidi ve hipoparatiroidi olmak üzere iki ana gruba ayrılır ve her ikisi de önemli nörolojik tutulumlara yol açabilir. Primer, sekonder ve tersiyer olarak incelenen hiperparatiroidi, genellikle kalsiyum yüksekliği (hiperkalsemi) ile seyreder; letarji, konfüzyon, miyalji, derin tendon reflekslerinde azalma ve nadiren ensefalopati gibi santral ve periferik sinir sistemi bulgularına neden olur. Hipoparatiroidizm ise düşük serum kalsiyumu ve yüksek fosfor seviyeleriyle karakterize olup, sıklıkla cerrahi operasyonlar veya otoimmün süreçler sonucu gelişir. Hipokalsemiye bağlı nöromusküler hiperirritabilite, tetani, uyuşukluk, nöbetler ve karpopedal spazm (Trousseau ve Chvostek bulguları) gibi akut veya kronik semptomlarla kendini gösterir. Uzun süreli hipokalsemi, kalsiyumun bazal ganglionlarda birikmesine yol açarak Fahr Hastalığına (ilerleyici idiyopatik strio-pallido-dentat kalsinozis) zemin hazırlayabilir; bu durum ekstrapiramidal bozukluklar, hareket kısıtlılığı ve nöropsikiyatrik semptomlarla karakterizedir. Tedavide kalsiyum ve magnezyum replasmanı ile D vitamini takviyesi metabolik süreçleri düzeltmede temel rol oynar.
Parathyroid hormone (PTH) is an 84-amino acid polypeptide that regulates calcium and phosphate homeostasis by acting on the bones, kidneys, and intestines. Parathyroid disorders are categorized into hyperparathyroidism and hypoparathyroidism, both causing significant neurological manifestations. Hyperparathyroidism, classified as primary, secondary, or tertiary, typically presents with hypercalcemia, leading to central and peripheral nervous system symptoms such as lethargy, confusion, myalgia, decreased deep tendon reflexes, and rarely encephalopathy. Conversely, hypoparathyroidism is characterized by low serum calcium and high phosphorus levels, commonly triggered by thyroid/parathyroid surgeries or autoimmune conditions. It manifests primarily through hypocalcemia-induced neuromuscular hyperirritability, causing acute or chronic symptoms like tetany, paresthesia, seizures, and carpopedal spasms, easily detected via Chvostek and Trousseau signs. Prolonged hypocalcemia can lead to intracranial calcifications in the basal ganglia, resulting in Fahr's Disease (progressive idiopathic strio-pallido-dentate calcinosis). This neurodegenerative disorder triggers extrapyramidal symptoms, movement disorders, and neuropsychiatric disturbances. Management relies strictly on regulating calcium metabolism through intravenous or oral calcium replacement, magnesium correction, and vitamin D supplementation to stop clinical progression.
Referanslar
Aguilera IM, Vaughan RS. Calcium and the anaesthetist. Anaesthesia 2000; 55:779-90.
Denker C. Sıvı ve elektrolid dengesizlikleri olan hastalara yaklaşım. In: Morgan GE, Mikail MS, Murray MJ (Eds), (Tulunay M, Cuhruk H Çev Eds.). Lange Klinik Anesteziyoloji. Güneş Tıp Kitabevleri. Ankara, 2008:662–89.
Baran DT, Aronin N. Disorders of mineral metabolism. In: Irwin RS, Rippe JM, eds. Irwin and Rippe’s Intensive Care Medicine. 6th ed. Philadelphia: Lippincott Williams & Wilkins 2008:1287-93.
Aurbach GD, Marx SJ, Spiegel AM. Parathyroid hormone, calcitonin and the calciferols. In: Wilson JD, Foster DW, eds. Williams Textbook of endocrinology, 8th edn. Philadelphia: W.B. Saunders 1992:1397-476.
Kaya T, Nalbant A, Varım C, Tamer A. Paratiroid hormon düşüklüğü: 107 olgunun etiyolojik olarak değerlendirilmesi. Ortadoğu Tıp Dergisi. 2013; 5 (1): 1-5.
Michels MC, Kelly KM. Parathyroid Disorders. Am Fam Physician. 2013; 88 (4): 249-57.
Uludağ M. Tiroid ve paratiroid cerrahisi sonrası hipokalsemi ve tedavisi. Şişli Etfal Eğitim ve Araştırma Hastanesi Tıp Bülteni. 2014; 48 (3): 161-175.
Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010; 5 (Suppl): 23-30. doi: 10.2215/CJN.05910809
Khan MI, Waguespack SG, Hu MI. Medical management of postsurgical hypoparathyroidism. Endocr Pract. 2011; 17 (1): 18-25. doi: 10.4158/EP10302.RA
Christou N, Mathonnet M. Complications after total thyroidectomy. J Visc Surg. 2013; 150: 249-56. doi: 10.1016/j.jviscsurg.2013.04.003
Moore EW. Ionised calcium in normal serum, ultrafiltrates, and whole blood determined by ion exchange electrodes. Journal of Clinical Investigation 1970; 49:318-34.
Ulusoy N, Polat C. Sıvı-elektrolid dengesi bozuklukları. Şahinoğlu AH (Editör). Yoğun Bakım Sorunları ve Tedavileri. 2. Baskı Türkiye Klinikleri yayın seri no:23, Ankara, 2003:214-34.
Aydede H. Sıvı ve elektrolid dengesi. In: Miller RD (Ed), (Aydın D, Çev. Ed.), Miller Anestezi. İzmir Güven Kitapevi. İzmir, 2010:1763-98.
Döşemeci L, Çelikbilek G, Akın FP. Asit-baz, sıvılar ve elektrolitler. In: Barash GP, Cullen BF, Stoelting RK, Cahalan MK, Stock MC (Eds), (Gunaydin B, Demirkıran O, Çev. Eds.), Klinik Anestezi. Nobel Tıp Kitapevi. 5. Baskı İstanbul, 2012:175-209.
Tanakol R. Kalsiyum-Fosfor ve Kemik Metabolizması: Kalsiyumu Regüle Eden Hormonlar. Ed: Sencer E. Endokrinoloji, Metabolizma ve Beslenme Hastalıkları, Nobel Tıp Kitabevi, İstanbul, 557-568, 2001.
Akoğlu E., Suleymanlar G. Kronik Bobrek Yetmezli. i. Ed: Ünal, Biberoğlu, Akalın, Süleymanlar. Temel iç Hastalıkları Ankara, Güneş Kitabevi., Ankara, 769- 777,1996.
Leonard RS. Hypercalcemia. In: Michael TD. Endocrine Secrets 2nd Ed. Harley & Belfus Inc., Philedelphia,81-101,1998.
Brunaud L, Ngueyon Sime W, Filipozzi P, et al. Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis. Surgery 2016; 159: 183-91.
Skorecki K, Gren J, Brenner BM. Chronic Renal Failure. In: Harrison’s Principle’s Of Medicine, 15 th edition, The McGraw-Hill Companies, New York, 1551-62,2004
Schreiner GE. Uremia. In: Textbook Of Nephrology, 2 nd edition, Williams & Wilkins, Baltimore, USA, 540-547,1989.
Kaminsky P, Robin-Lherbier B, Brunotte F, et al. Energetic metabolism in hypothyroid skeletal muscle. Pamukkale Tıp Dergisi 2013;6(2):108-117 Örük ve ark.
Kooh S-W, binet A: Hypercalcemia in infants presenting with apne. Canadian Mediacal Association Journal 143:509, 1990
Patten BM, Page M: Severe neurological disease associated with hyperparatiroidism. Annals of Neurology 15:453,1984
Kim JH, Kim MJ, Kank JK, et al: Vasogenic edma in a case of hypercalcemia-induced posterior reversble encephalopty. European Neurology 53:160,2005.
Riggs JE: Neurologic manifestations of electrolyte disturbances. Neurologıc Clinics 20:227, 2002
Patten BM, Bilezikian JP, Mallette LE, et al: Neuromusculer disease in primary hyperparatiroidism. Annals of Internal Medicine 80:182,1974
Rao DS, Philips ER, Divind GW, Talpos GB. Randomized controlled clinical trial of surgery vs no surgery in patients with mild PHPT. The Journal of Clinical Endocrinology & Metabolısm 2004; 89:5415-5422
Bilezikian JP, Khan A, Potts JT Jr. Guidelines for the manage-ment of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. The Journal of Clinical Endocrinology & Metabolısm. 2009; 94:335–9.G-10.
Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. New England Journal of Medicine. 2004; 350:2068–79.
Goltzman D, Cole DEC. Hypoparathyroidism. In primer on the Metabolic Bone Diseases and Disorders of Bone Metabolism, American Society of Bone and Mineral Research 2006; 6:216
Ishikawa Y, Bianchi C, Nadal-Ginard B, Homcy CJ. Alternati-ve promoter and 5' exon generate a novel Gs alpha mRNA. Journal of Biological Chemmistry 1990; 265:8458.
Farfel Z, Brothers VM, Brickman AS, et al. Pseudohypopa-rathyroidism: inheritance of deficient receptor-cyclase coupling activity. Proceeding of the National Academy of Scienceof the United Staties of America 1981; 78:3098.
Rodriguez HJ, Villarreal H Jr, Klahr S, Slatopolsky E. Pseudohypoparathyroidism type II: restoration of normal renal res-ponsiveness to parathyroid hormone by calcium administration. The Journal of Clinical Endocrinology & Metabolısm. 1974; 39:693.
Drezner M, Neelon FA, Lebovitz HE. Pseudohypoparathyroi-dism type II: a possible defect in the reception of the cyclic AMP signal. New England Journal of Medicine 1973; 289:1056.
Howland WS, Schweizer O, Jascott D, Ragasa J. Factors influencing the ionization of calcium during major surgical procedures. Surgery Gynaecolgy Obstetri 1976; 143:895-900.
Goltzman D, Rosen CJ, Mulder JE. Clinical manifestations of hypocalcemia. www.uptodate.com/contents/clinical-manifestations-of-hypocalcemia?Accessdate29.05.2014.
Shoback D. Clinical practice. Hypoparathyroidism. New England Journal of Medicine. 2008; 359:391–403.
Bilezikian JP, Khan A, Potts JT Jr, et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. Journal of Bone and Mineral Research. 2011; 26:2317–2337.
De Sanctis V, Soliman A, Fiscina B. Hypoparathyroidism: from diagnosis to treatment. Current Opinion in Endocrinology Diabetes and Obesity. 2012; 19:435–442.
Goswami R, Millo T, Mishra S, et al. Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for basal ganglia calcification in hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolısm. 2014; 99:1741–1748.
Srirangarajan S, Satyanarayan A, Ravindra S, Thakur S. Dental manifestation of primary idiopathic hypoparathyroidism. Journal of Indian Society Periodontology. 2014; 18:524–526.
Mannstadt MM, Mitchell DM. Clinical manifestations of ypoparathyroidism. In: Bilezikian JP, Marcus R, LevineMA,Marcocci C, Silverberg SJ, Potts JT Jr, eds. The parathyroids. London, UK: Academic Press; 2015:761–770.
Shoback D. Clinical practice. Hypoparathyroidism. New England Journal of Medicine. 2008;359: 391-403.
Cusano NE, Rubin MR, McMahon DJ, et al. The effect of PTH (1-84) on quality of life in hypoparathyroidism. The Journal of Clinical Endocrinology & Metabolısm. 2013; 98 (6) :2356-61. doi: 10.1210/jc.2013-1239
Cusano NE, Rubin MR, McMahon DJ, et al. PTH (1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J Clin Endocrinol Metab. 2014; 99 (10): 3694-9. doi: 10.1210/jc.2014-2267
Örük GG, Bahçeci M. Tiroid ve paratiroid hastalıklarında nöromuskuler sistem bulguları. Pamukkale Tıp Dergisi 2013; 6 (2): 108-17.
Clarke BL. Bone disease in hypoparathyroidism. Arquivos Brasileiros de Endocrinologia e Metabologia. 2014; 58 (5): 545-52.
Bilezikian JP, Khan A, Jr Potts JT, et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. Journal of Bone and Mineral Research. 2011; 26 (10): 2317-37. doi: 10.1002/jbmr.483
Shoback DM, Bilezikian JP, Costa AG, et al. Presentation of Hypoparathyroidism: Etiologies and Clinical Features. The Journal of Clinical Endocrinology & Metabolısm. 2016; 101 (6) 2300-12. doi: 10.1210/jc.2015-3909
Uslu Fİ, Hanağası HA. Hipoparatroidizm ve Bilateral Striopallidodentat Kalsinozis. Nöropsikiyatri Arşivi 2006; 43: 31-36
Benke T, Karner E, Seppi K, Delazer M, Marksteiner J, Donnemiller E, Subacute dementia and imaging correlates in a case of Fahr’s disease. Journal of Neurology, Neurosurgery and Psychiatry. 2004;75: 1163-65
Duckett S, Galle P, Escourolle R, Poirier J, Hauw JJ. Presence of zinc, aluminum, magnesium in striopallidodentate (SPD)calcifications (Fahr’s disease): electron probe study. Acta Neuropathologica 1977; 38: 7-10
Kökeş Ü, Hız F, Özden DL, Çınar M. Psödohipoparatiroidinin Yol Açtığı Bir Fahr Sendromu Olgusu. Parkinson Hastalığı ve Hareket Bozuklukları Dergisi 2009; 12: 18-24
Sert M, Gökel Y, Tetiker T, Koçak M, Tiroid operasyonları sonrası ciddi komplikasyonların geliştiği bir hipoparatiroidi vakası. Çukurova Üniversitesi Tıp Fakültesi Dergisi 1998; 23: 55-58
Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Jüppner H, D'Amour P, Fox J, Rejnmark L, Mose-kilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treat-ment, and challenges for future research. Journal of Bone and Mineral Research. 2011 Oct;26(10): 2317-37.
Shoback D. Hypoparathyroidism. New England Journal of Medicine. 2008; 359: 391-403.
Fahr I. Idiopathipathische verkalking der hirume fasse. Zbl Allf Path 1930;50: 129-33
Kobayashi S, Yamadori I, Miki H, Ohmori M. Idiopathic nonarteriosclerotic cerebral calcification (Fahr’s disease): an electron microscopic study. Acta Neuropathologica 1987;73(1):62-6.
Bouras C, Giannakopoulos P, Good PF, Hsu A, Hof PR, Perl DP. A Laser microprobe mass analysis of the trace ele¬ments in brain mineralizations and capillaries in Fahr’s disea¬se. Acta Neuropathologica 1989; 26:569-75.
Kazis AD. Contribution of CT scan to the diagnosis of Fahr’s syndrome. Acta Neuropathologica 1985; 71:206-11.
Ökten Aİ, Ergün R. Fahr’s Hastalığı (İleryici İdiyopatik Strio-Pallido-Dentat Kalsinozis): Vaka Sunumu. Türk Serebrovasküler Hastalıklar Dergisi 2003;9(2):77-9.
Baptista MV, Vale J, Leitao O. Strio-pallido-dentat calcifica¬tions. La Presse Medicale 1995;24(28):1301-4.
Rossi M, Morena M, Zanardi M. Calcification of the basal ganglia and Fahr disease. Report of two clinical cases and review of the literature. Recenti Progressi in Medicana. 1993;84(3):192-8.
Manyam BV. What is and what is not ‘Fahr’s disease’. Parkinsonism and Related Disorders 2005; 11: 73-80
Lew SQ. Hydrothorax: pleural effusion associated with peritoneal dialysis. Peritoneal Dialysis International 2010; 30:13-18.
Ramon RG, Carrasco AM: Hydrothorax in peritoneal dialysis. Peritoneal Dialysis International 1998; 18:540-546.
Lam JSP, Fong SYY, Yiu GC, Wing YK. Fahr’s disease: a differential diagnosis of frontal lobe syndrome. Hong Kong Medical Journal 2007; 13: 75-7
Yoshikawa H, Abe T. Transient parkinsonism in bilateral striopallidodentate calcinosis. Pediatric Neurology 2003; 29:75-7.
Lauterbach EC. Fahr’s Syndrome. In: Psychiatric manage¬ment in neurological disease. 1st ed. Washington: American Psychiatric Press; 2000:137-8.
Edward SR, Unger AM: Acute hydrothorax: a new complication of peritoneal dialysis. The Journal American Medical Association 1967; 199:853-855.
Kartal İ, Şahpolat M, Kokaçya M.H, Atçı N. Fahr Hastalığı: Beş olgu sunumu. Mustafa Kemal Üniv. Tıp Derg, 2013; cilt:5, sayı: 15
Erus T, Acar S, Aktuğlu MB, Karaaali ZE, Kendir M, Nadir bir hipokalsemi nedeni: Fahr Hastalığı İstanbul Tıp Fakültesi Dergisi 2010; 73: 3
Modrego PJ, Mojonero J. Fahr’s syndrome presenting with pure and progresive presenil dementia. Neurological Sciences 2005; 26: 367-69
Faria AV, Pereira IC. Computerized tomograpry findings in Fahr’s syndrome. Arquivos de Neuro-Psiquatria 2004; 62: 789- 92
Warren JD, Mummery CJ. Corticobasal degeneration syndrome with basal ganglia calcification: Fahr’s disease as a corticibasal look-alike? Movement Disorders 2002; 17: 563-67
